Nanotechnology Informs the Newest Blood Test for Cancer

    With the help of nanotechnology, scientists can now find the one cancerous cell in a blood sample. A new device, called the circulating tumor cell chip, or CTC, was developed at Massachusetts General Hospital by a team of oncologists and bioengineers and is about the size of a credit card. It separates normal blood cells from cancer cells using microscopic magnetic beads. Previously, to test for cancer, doctors needed to take a biopsy, which can be risky when tumors are in hard-to-reach organs like the lungs.

    The assay has worked on patients with known lung cancer, and now researchers are trying it, in conjunction with computed tomography (CT) scans, on people not known to have the disease. It could also help doctors quickly determine the efficacy of a given medication by being able to test a patient’s blood before and after treatment.

    illustration by Carl wiens
    Lessons learned from early organ recipients continue to hearten the future of transplant medicine....
    Could our reaction to an image of an overweight or obese person affect how we perceive odor? A trio...
    Molecular inhibitor represents new treatment target for drugs to halt atherosclerosis Working with...
    Gene Variation Affects Brain Cell Development Johns Hopkins researchers have begun to connect the...
    Molecular “Eat Now” Sign Makes Cells Devour Dying Neighbors A team of researchers has devised a Pac...
    Star-shaped brain cells may help control brain’s focus A new study from The Johns Hopkins...
    Discoveries hail from cataloging human proteins Striving for the protein equivalent of the Human...
    Compounds in saliva may fend off chemicals in tea and coffee A compound in saliva, along with...
    Scientists discover how tumor cells divide when oxygen-starved Most cells do not divide unless...
    Tumor cells penetrated by particles carrying genetic instructions. Working together, Johns Hopkins...